Abu Dhabi whitepaper outlines framework for integrating wearables into preventive healthcare
The report examines how wearable devices could support earlier risk detection, personalised prevention and more continuous health monitoring.
AstraZeneca and Oracle plan global AI collaboration, with first programme in Abu Dhabi
In partnership with healthcare company M42, the initial programme will focus on hypertension care and clinical research.
Abu Dhabi opens applications for global digital health innovation challenge
The Future Health Digital Innovation Challenge 2026 competition will focus on fertility, population health and wellbeing, with three finalists sharing a US$105,000 prize pool.
Four medtech startups to compete for USD 175,000 Grand Prize in Singapore
The finalists are Ardens Lifescience of South Korea, BaiYi Healthcare of China, Eyes of AI of Australia, and Physiologas Technologies of Japan.
South Korea to host World Bio Summit on AI-driven healthcare innovation
The 2026 World Bio Summit will bring together government officials, healthcare professionals and industry representatives to discuss the role of AI in healthcare and the biohealth sector.
Abu Dhabi Biobank partners with Cleveland Clinic Abu Dhabi on cancer research
The initiative aims to bring together germline data relating to inherited genetic variation, tumour sequencing and laboratory research models within a centralised resource.
China outlines ethical governance framework for embodied AI
The report treats the ethics of embodied intelligence as part of broader AI ethics, while identifying risks arising from the direct interaction between intelligent systems, people and their surroundings.
Cleveland Clinic Abu Dhabi uses robotic surgery in preventive colorectal cancer procedure
The case highlights the application of robotic-assisted surgery in complex preventive procedures for patients with a high inherited risk of cancer.
M42 to showcase AI-driven health intelligence at Abu Dhabi Future Health Summit
M42 said it would demonstrate how its capabilities across clinical care, genomics, biobanking, AI and digital health could support earlier identification of health risks.